Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high‐fat diet in the genetically diverse Collaborative Cross mouse model-Reference-Cited by-同舟云学术

Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high‐fat diet in the genetically diverse Collaborative Cross mouse model

Published:2020-04-18 Issue:6 Volume:34 Page:7773-7785
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Conti Aline¹,Tryndyak Volodymyr¹,Willett Rose A.¹,Borowa‐Mazgaj Barbara¹,Watson Anna¹,Patton Ralph²,Khare Sangeeta³,Muskhelishvili Levan²,Olson Greg R.²,Avigan Mark I.⁴,Cerniglia Carl E.³,Ross Sharon A.⁵,Sanyal Arun J.⁶,Beland Frederick A.¹,Rusyn Ivan⁷,Pogribny Igor P.¹

Affiliation:

1. Division of Biochemical Toxicology FDA‐National Center for Toxicological Research Jefferson AR USA

2. Toxicologic Pathology Associates Jefferson AR USA

3. Division of Microbiology FDA‐National Center for Toxicological Research Jefferson AR USA

4. Office of Pharmacovigilance and Epidemiology FDA‐Center for Drug Evaluation and Research Silver Spring MD USA

5. Division of Cancer Prevention National Cancer Institute Bethesda MD USA

6. Department of Internal Medicine Virginia Commonwealth University Richmond VA USA

7. Department of Veterinary Integrative Biosciences Texas A&M University College Station TX USA

Funder

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202000194R

Reference60 articles.

1. Human Fatty Liver Disease: Old Questions and New Insights

2. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

3. Non‐alcoholic fatty liver disease (NAFLD), active component, U.S. Armed Forces, 2000–2017;Williams VF;MSMR,2019

4. Non-alcoholic fatty liver disease – A global public health perspective

5. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice;Toxicology and Applied Pharmacology;2024-10

2. Nesfatin-1 and nesfatin-1-like peptide attenuate hepatocyte lipid accumulation and nucleobindin-1 disruption modulates lipid metabolic pathways;Communications Biology;2024-05-27

3. Genomics in Toxicology;Reference Module in Biomedical Sciences;2024

4. Transcriptome analysis revealed FABP5 as a serum marker of metabolic associated fatty liver disease;2023-12-06

5. Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population;Journal of Lipid Research;2023-12